Wake up, South Africa! The antibiotic 'horse' has bolted

South African Medical Journal

Volumn 102, Issue 7, 2012, Pages 607-608

  Mendelson, Marc ^a   Whitelaw, Andrew ^b   Nicol, Mark ^c   Brink, Adrian ^d  

^a Federation of Infectious Diseases Societies of Southern Africa   (South Africa)

^b Infection Control Society of Southern Africa   (South Africa)

^c South African Society for Clinical Microbiology   (South Africa)

^d South African Antibiotic Stewardship Programme   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; COLISTIN; METALLO BETA LACTAMASE; VANCOMYCIN;

BACTERIAL INFECTION; EDITORIAL; ENTEROBACTERIACEAE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCRIPTION; RISK FACTOR; TRAINING;

EID: 84863742758     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.5759     Document Type: Editorial

References (11)

1. Communicable Diseases Communique. Outbreak of newly emerged, highly antibiotic resistant bacteria in hospitalized patients in Gauteng Province: New Delhi metallo-beta-lactamase (NDM-1). NICD Communique 2011;10(10):2-3.
2. Brink AJ, Coetzee J, Clay C, et al. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol 2012;50:525-527. [PMID: 22116157]
3. Shlaes D, Gerding D, John Jr J, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-599. [PMID: 9314444]
4. Hassan M, Tuckman HP, Patrick RH, Kountz DS, Kohn JL. Cost of hospital-acquired infection. Hosp Top 2010;88(3):82-89. [PMID: 20805070]
5. Denton M, Kerr K, Mooney L, et al. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center. Pediatr Pulmonol 2002;34(4):257-261. [PMID: 12205566]
6. Falgas ME, Rafilidis PI, Matthaiou DK, et al. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 2008;32:450-454. [PMID:18768302]
7. Lee JY, Lim MH, Heo ST, Ko KS. Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymixins and carbapenems from 1 patient. Diagn Microbiol Infect Dis 2012;72(3):267-271. [PMID: 22217703]
8. Brink A, Coetzee J, Clay C, et al. The spread of carbapenem-resistant Enterobacteriaceae (CRE) in South Africa: Risk factors for acquisition and prevention. S Afr Med J 2012;102(7):599-601 (this issue).
9. Best Care.... Always! http://www.bestcare.org.za (accessed 19 February 2012).
10. Visser A, Moore DP, Whitelaw A, et al. GARP: Part VII. Interventions. S Afr Med J 2011;101(8, Pt 2):587-595.
11. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005;18:638-656. [PMID: 16223951]